Print

GlaxoSmithKline (GSK) (JOBS), Vernalis PLC (VNLS) Sign up to $200 Million Cancer Deal  
8/6/2009 7:30:11 AM

Bookmark and Share

Reuters -- GlaxoSmithKline Plc, the world's second-largest drugmaker, has signed a deal potentially worth $200 million with British biotech company Vernalis Plc (VER.L) to boost its early-stage research in cancer.

//-->